These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Therapeutic application of calcium-channel antagonists for pulmonary hypertension. Packer M Am J Cardiol; 1985 Jan; 55(3):196B-201B. PubMed ID: 3881914 [TBL] [Abstract][Full Text] [Related]
6. Calcium blockage in pulmonary hypertension and hypoxic vasoconstriction. Neely CF; Stein R; Matot I; Batra V; Cheung A New Horiz; 1996 Feb; 4(1):99-106. PubMed ID: 8689279 [TBL] [Abstract][Full Text] [Related]
7. Calcium channel blockers in hypoxic pulmonary hypertension. Kennedy TP; Michael JR; Summer W Am J Med; 1985 Feb; 78(2B):18-26. PubMed ID: 3976691 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of dobutamine, dopamine, and isoproterenol on hypoxic pulmonary vasoconstriction in the pig. Furman WR; Summer WR; Kennedy TP; Sylvester JT Crit Care Med; 1982 Jun; 10(6):371-4. PubMed ID: 7075232 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of minoxidil and nifedipine on hypoxic pulmonary vasoconstriction in dogs. Bishop MJ; Cheney FW J Cardiovasc Pharmacol; 1983; 5(2):184-9. PubMed ID: 6188887 [TBL] [Abstract][Full Text] [Related]
11. The effects of agents that bind to cytochrome P-450 on hypoxic pulmonary vasoconstriction. Sylvester JT; McGowan C Circ Res; 1978 Sep; 43(3):429-37. PubMed ID: 679425 [TBL] [Abstract][Full Text] [Related]
12. Urapidil, but not dihydropyridine calcium channel inhibitors, preserves the hypoxic pulmonary vasoconstriction: an experimental study in pig arteries. Bopp C; Auger C; Mebazaa A; Joshi GP; Schini-Kerth VB; Diemunsch P Fundam Clin Pharmacol; 2019 Oct; 33(5):527-534. PubMed ID: 30811659 [TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of nifedipine in normoxic and hypoxic newborn lambs. Philips JB; Lyrene RK; Leslie GI; McDevitt M; Cassady G Pediatr Pharmacol (New York); 1985; 5(1):23-30. PubMed ID: 3991251 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of hypoxic pulmonary vasoconstriction by nifedipine. Simonneau G; Escourrou P; Duroux P; Lockhart A N Engl J Med; 1981 Jun; 304(26):1582-5. PubMed ID: 7231503 [No Abstract] [Full Text] [Related]
16. Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with cystic fibrosis and cor pulmonale. Michael JR; Kennedy TP; Fitzpatrick S; Rosenstein BJ Am Rev Respir Dis; 1984 Sep; 130(3):516-9. PubMed ID: 6476600 [TBL] [Abstract][Full Text] [Related]
17. Nifedipine inhibits pulmonary hypertension but does not prevent decreased lung eNOS in hypoxic newborn pigs. Fike CD; Kaplowitz MR Am J Physiol; 1999 Sep; 277(3):L449-56. PubMed ID: 10484451 [TBL] [Abstract][Full Text] [Related]
18. Effects of dexfenfluramine on hypoxic pulmonary vasoconstriction and embolic pulmonary hypertension in dogs. Naeije R; Wauthy P; Maggiorini M; Leeman M; Delcroix M Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 1):692-7. PubMed ID: 7881658 [TBL] [Abstract][Full Text] [Related]
19. Comparative effects of nisoldipine, nifedipine and bepridil on experimental pulmonary hypertension. Archer SL; Yankovich RD; Chesler E; Weir EK J Pharmacol Exp Ther; 1985 Apr; 233(1):12-7. PubMed ID: 3872360 [TBL] [Abstract][Full Text] [Related]
20. Dithionite increases radical formation and decreases vasoconstriction in the lung. Evidence that dithionite does not mimic alveolar hypoxia. Archer SL; Hampl V; Nelson DP; Sidney E; Peterson DA; Weir EK Circ Res; 1995 Jul; 77(1):174-81. PubMed ID: 7788875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]